PMID- 36472340 OWN - NLM STAT- MEDLINE DCOM- 20230329 LR - 20230329 IS - 1532-2335 (Electronic) IS - 1525-7770 (Linking) VI - 42 IP - 5 DP - 2023 TI - TNF-alpha promoter variant (G-308A) is associated with susceptibility to P. falciparum infection and severe malaria: a meta-analysis and trial sequential analysis. PG - 381-397 LID - 10.1080/15257770.2022.2151622 [doi] AB - Tumor necrosis factor-alpha (TNF-alpha) plays an essential role in Plasmodium falciparum infection, with lower levels associated with susceptibility to infection and higher levels linked with organ failure in severe malaria. Genetic polymorphisms in the promoter region of the TNF-alpha gene (G-308A and G-238A) affect plasma TNF-alpha levels. Numerous case-control studies have been conducted to determine the possible association between TNF-alpha polymorphisms and susceptibility to malaria infection and clinical severity; however, the results are inconsistent. Various databases such as Google Scholar, Science Direct, PubMed, and Scopus were searched for relevant articles for the present meta-analysis. Data were extracted from the eligible studies based on inclusion and exclusion criteria. Meta-analysis was carried out with CMA v.3.3.070 software, and combined odds ratio, 95% confidence interval, and p values were calculated. Further, a trial sequential analysis was also performed to test whether enough number of case and controls have been enrolled to date to draw a valid conclusion. Allele (OR = 9.757, p value=.049) and heterozygous (OR = 8.98, p value=.016) comparison model revealed the TNF-alpha G-308A variant as a susceptible genetic factor for P. falciparum infection. Similarly, a significant association of TNF-alpha G-308A polymorphism with P. falciparum malarial severity was also observed (A versus G: OR = 1.761, p value = .000; and GG + GA versus GG: OR = 1.769, p value = .000). However, no association of TNF-alpha (G-238A) polymorphism was observed with infection and severity of P. falciparum or Plasmodium vivax malaria. TNF-alpha G-308A variant is associated with susceptibility to P. falciparum infection and clinical severity. However, further studies on different populations are required. FAU - Sarangi, Surjyapratap AU - Sarangi S AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Nahak, Suraj Kuamr AU - Nahak SK AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Padhi, Sunali AU - Padhi S AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Nayak, Nisha AU - Nayak N AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Pradhan, Bidyutprabha AU - Pradhan B AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Pati, Abhijit AU - Pati A AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Panigrahi, Jogeswar AU - Panigrahi J AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. FAU - Panda, Aditya K AU - Panda AK AUID- ORCID: 0000-0002-1192-1978 AD - P.G. Department of Biotechnology, Berhampur University, Berhampur, India. LA - eng PT - Journal Article PT - Meta-Analysis DEP - 20221206 PL - United States TA - Nucleosides Nucleotides Nucleic Acids JT - Nucleosides, nucleotides & nucleic acids JID - 100892832 RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Humans MH - *Tumor Necrosis Factor-alpha/genetics MH - Genetic Predisposition to Disease MH - Polymorphism, Genetic MH - Promoter Regions, Genetic MH - *Malaria/genetics MH - Polymorphism, Single Nucleotide OTO - NOTNLM OT - Plasmodium falciparum OT - TNF-alpha OT - association OT - gene polymorphism OT - meta-analysis OT - severe malaria EDAT- 2022/12/07 06:00 MHDA- 2023/03/29 06:05 CRDT- 2022/12/06 07:23 PHST- 2023/03/29 06:05 [medline] PHST- 2022/12/07 06:00 [pubmed] PHST- 2022/12/06 07:23 [entrez] AID - 10.1080/15257770.2022.2151622 [doi] PST - ppublish SO - Nucleosides Nucleotides Nucleic Acids. 2023;42(5):381-397. doi: 10.1080/15257770.2022.2151622. Epub 2022 Dec 6.